Literature DB >> 1306686

The interaction of amphiregulin with nuclei and putative nuclear localization sequence binding proteins.

B Modrell1, V L McDonald, M Shoyab.   

Abstract

Amphiregulin (AR) is a 23 kDa, bifunctional growth modulating glycoprotein belonging to the epidermal growth factor (EGF) family of polypeptide growth regulators. AR possesses two putative nuclear localization sequences (NLS), binds to DNA sepharose, and localizes to the nucleoli of human ovarian surface epithelial carcinoma cells suggesting that AR has a direct nuclear role. We have found that 125I-labeled AR, when exogenously applied to several carcinoma cell lines, associated with nuclei in a time, temperature, and concentration dependent fashion. The control peptide, EGF, also associated with these fractions but at approximately 20% of the efficiency of AR. Cross-linking experiments with 125I-labeled AR and nuclear fractions derived from various carcinoma and normal cell lines demonstrated that AR binds two proteins of molecular mass 205 and 120 kDa. AR binding to these nuclear fraction proteins was specific and saturable as shown by competition experiments utilizing both SV-40 large T antigen NLS and an AR derived peptide encompassing both putative AR NLS. The combined results suggest that nuclear interactions may play a significant role in AR induced growth responses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1306686     DOI: 10.3109/08977199209046413

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  9 in total

1.  Topography of amphiregulin expression in cultured human keratinocytes: colocalization with the epidermal growth factor receptor and CD44.

Authors:  N Nylander; L T Smith; R A Underwood; M Piepkorn
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

Review 2.  Amphiregulin as a novel target for breast cancer therapy.

Authors:  Nicole E Willmarth; Stephen P Ethier
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-04-25       Impact factor: 2.673

Review 3.  Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.

Authors:  N Normanno; F Ciardiello; R Brandt; D S Salomon
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

Review 4.  Bioinformatic analysis of the nucleolus.

Authors:  Anthony K L Leung; Jens S Andersen; Matthias Mann; Angus I Lamond
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

5.  Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells.

Authors:  N Normanno; M P Selvam; C F Qi; T Saeki; G Johnson; N Kim; F Ciardiello; M Shoyab; G Plowman; R Brandt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Induction of amphiregulin by p53 promotes apoptosis via control of microRNA biogenesis in response to DNA damage.

Authors:  Naoe Taira; Tomoko Yamaguchi; Junko Kimura; Zheng-Guang Lu; Shinji Fukuda; Shigeki Higashiyama; Masaya Ono; Kiyotsugu Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

Review 7.  The role of amphiregulin in breast cancer.

Authors:  D S Salomon; N Normanno; F Ciardiello; R Brandt; M Shoyab; G J Todaro
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

8.  Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.

Authors:  Glen A Doherty; Sinead M Byrne; Eamonn S Molloy; Vikrum Malhotra; Sandra C Austin; Elaine W Kay; Frank E Murray; Desmond J Fitzgerald
Journal:  BMC Cancer       Date:  2009-06-26       Impact factor: 4.430

9.  Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.

Authors:  C F Qi; D S Liscia; N Normanno; G Merlo; G R Johnson; W J Gullick; F Ciardiello; T Saeki; R Brandt; N Kim
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.